Skip to main content
Signal8

Nordicus Partners Corp (NORD)

Nordicus Partners Corporation functions as a publicly traded entity that acts as both a business accelerator and a holding company, specifically supporting Nordic life sciences firms operating within the United States. A central focus for the company involves advancing oral healthcare through the development of new medicines. In addition to its core operations, Nordicus offers an array of corporate finance and advisory services. These include aiding in business and market expansion, formulating strategic growth plans, identifying and acquiring talent, fostering key partnerships, facilitating capital raising efforts, and orchestrating company acquisitions or sales. The organization, which was established in 1993 and is headquartered in Beverly Hills, California, rebranded as Nordicus Partners Corporation in May 2023, having previously been known as EKIMAS Corporation.

Sector: Services-Management Consulting Services

Industry: Biotechnology

Nordicus Partners Corporation logo

Nordicus Partners Corporation

NASDAQ:NORDIndustrials
AH+0.00%$2.76
Close$2.76-3.83%
Mkt Cap$55.16M
EV-
Float5.34M
O/S19.98M
VOL9K sh
$ Vol$27K
RVOL0.56×
Inst Own-
SI0.1%
Net Cash/Sh-
Dilution
Nordicus Partners Corporation logoNASDAQ:NORDAH$2.76+0.00%
FormDescription
PRE 14C
SEC Filing
NT 10-Q
SEC Filing
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
4
Statement of Changes in Beneficial Ownership
8-K
8-K
3.02,9.01
CERT
SEC Filing
8-A12B
SEC Filing
8-K
8-K
10-Q
8-K
8-K
NT 10-Q
SEC Filing
10-K
8-K
NT 10-K
SEC Filing
8-K
10-Q
Quarterly Report
8-K
8.01,9.01
8-K
1.01,3.02,9.01
8-K
1.01,3.02,9.01
10-Q
Quarterly Report
4
Statement of Changes in Beneficial Ownership

1-25 of 622

…

Recent SEC filings with analysis

    Nordicus Partners Corp (NORD) SEC Filings: 10-K, 10-Q, 8-K | Signal8